Effect of catalase on endotoxin-induced acute lung injury in unanesthetized sheep.
Administration of endotoxin intravenously to unanesthetized sheep causes an acute lung injury characterized by increased microvascular barrier permeability and subsequent pulmonary edema. Endotoxin-induced sheep lung injury can be attenuated by leukocyte depletion, and may be mediated by toxic metabolites of oxygen. We studied effects of administering catalase, which catalyzes conversion of hydrogen peroxide to oxygen and water, to sheep subsequently infused with endotoxin to test the hypothesis that hydrogen peroxide plays a role in the pathogenesis of lung injury. We found that infusions of endotoxin (1 microgram/kg) into untreated sheep caused the expected biphasic response, a transient, early, marked pulmonary arterial hypertension followed by a prolonged increase in protein-rich lung lymph flow characteristic of increased microvascular permeability filtration in the lungs. Intraperitoneal injections of catalase (50 mg/kg) prior to infusing endotoxin in these same sheep resulted in substantial catalase activity in plasma and in lung lymph, and attenuated the expected changes in pulmonary arterial pressure, lung lymph flow, and arterial leukocyte counts and oxygen tension after endotoxin infusions. Furthermore, mechanical elevation of hydrostatic pressure in the lungs of a catalase-treated sheep infused with endotoxin resulted in increased lung lymph flow with a decreased protein concentration, indicating that the microvascular barrier to fluid and protein was functionally intact. Administration of catalase that was inactivated by reaction with hydrogen peroxide in the presence of aminotriazole or administration of the catalase vehicle, thymol, had no effects on the sheep responses to endotoxin. We conclude that hydrogen peroxide plays a role in the pathogenesis of endotoxin-induced acute lung injury in sheep.
Milligan
S A
SA
Medical Service, Rosalind Russell Arthritis Research Laboratory, San Francisco General Hospital Medical Center, California.
Hoeffel
J M
JM
Goldstein
I M
IM
Flick
M R
MR
D000208:Acute Disease; D000758:Anesthesia; D000818:Animals; D002374:Catalase / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000627:therapeutic use*; D002448:Cell Adhesion / Q000187:drug effects; D002478:Cells, Cultured; D004353:Drug Evaluation, Preclinical; D004731:Endotoxins / Q000633:toxicity*; D004926:Escherichia coli; D005260:Female; D006861:Hydrogen Peroxide / Q000378:metabolism; D008168:Lung / Q000187:drug effects / Q000201:enzymology; D008171:Lung Diseases / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control; D008196:Lymph / Q000187:drug effects / Q000201:enzymology; D009504:Neutrophils / Q000187:drug effects / Q000201:enzymology; D012756:Sheep; D012757:Sheep Diseases / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control; D013943:Thymol / Q000494:pharmacology
D004731:Endotoxins; D013943:Thymol; D006861:Hydrogen Peroxide; D002374:Catalase